Top
Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India
Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India
DOI: 10.1002/rcr2.780, Volume: 9, Issue: 8, Pages: 0-0
Article Type: case-report,
Article History
received:
accepted:
published:
-
-
-
- Altmetric
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.1002/rcr2.780&title=Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India&author=&keyword=[{keywordId=5473, uniqueName=mepolizumab, name=mepolizumab, contentId=258899}, {keywordId=34874, uniqueName=severe-asthma, name=Severe asthma, contentId=258899}, {keywordId=54879, uniqueName=asthma-control, name=asthma control, contentId=258899}, {keywordId=82483, uniqueName=eosinophilic-inflammation, name=eosinophilic inflammation, contentId=258899}, {keywordId=160212, uniqueName=severe-eosinophilic-asthma, last=true, name=severe eosinophilic asthma, contentId=258899}],[{keywordId=5473, uniqueName=mepolizumab, name=mepolizumab, contentId=258899}, {keywordId=34874, uniqueName=severe-asthma, name=Severe asthma, contentId=258899}, {keywordId=54879, uniqueName=asthma-control, name=asthma control, contentId=258899}, {keywordId=82483, uniqueName=eosinophilic-inflammation, name=eosinophilic inflammation, contentId=258899}, {keywordId=160212, uniqueName=severe-eosinophilic-asthma, last=true, name=severe eosinophilic asthma, contentId=258899}],[{keywordId=5473, uniqueName=mepolizumab, name=mepolizumab, contentId=258899}, {keywordId=34874, uniqueName=severe-asthma, name=Severe asthma, contentId=258899}, {keywordId=54879, uniqueName=asthma-control, name=asthma control, contentId=258899}, {keywordId=82483, uniqueName=eosinophilic-inflammation, name=eosinophilic inflammation, contentId=258899}, {keywordId=160212, uniqueName=severe-eosinophilic-asthma, last=true, name=severe eosinophilic asthma, contentId=258899}],[{keywordId=5473, uniqueName=mepolizumab, name=mepolizumab, contentId=258899}, {keywordId=34874, uniqueName=severe-asthma, name=Severe asthma, contentId=258899}, {keywordId=54879, uniqueName=asthma-control, name=asthma control, contentId=258899}, {keywordId=82483, uniqueName=eosinophilic-inflammation, name=eosinophilic inflammation, contentId=258899}, {keywordId=160212, uniqueName=severe-eosinophilic-asthma, last=true, name=severe eosinophilic asthma, contentId=258899}],[{keywordId=5473, uniqueName=mepolizumab, name=mepolizumab, contentId=258899}, {keywordId=34874, uniqueName=severe-asthma, name=Severe asthma, contentId=258899}, {keywordId=54879, uniqueName=asthma-control, name=asthma control, contentId=258899}, {keywordId=82483, uniqueName=eosinophilic-inflammation, name=eosinophilic inflammation, contentId=258899}, {keywordId=160212, uniqueName=severe-eosinophilic-asthma, last=true, name=severe eosinophilic asthma, contentId=258899}],&subject=
© 2024 Newgen KnowledgeWorks |
Privacy & Cookie Policy | Powered by: Nova